Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2017-06-22 2017-06-22
Drug Identification Number 00453617 00453617
Brand name EES-400 EES-400
Common or Proper name erythromycin ethylsuccinate oral suspension USP erythromycin ethylsuccinate oral suspension USP
Company Name AMDIPHARM LIMITED AMDIPHARM LIMITED
Ingredients ERYTHROMYCIN ERYTHROMYCIN
Strength(s) 400MG 400MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size All All
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-06-21 2017-06-21
Actual discontinuation date 2017-06-21 2017-06-21
Remaining supply date 2017-06-21 2017-06-21
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments